2021 Updates

Over the past year, investigators at the Richard T. Silver Myeloproliferative Neoplasms (MPN) Center –CR&T’s primary funding initiative — have made important advances in research, while providing compassionate care that enhances and prolongs patients’ lives.

Scroll down this page for videos on the latest research and a patient advocate’s story of her MPN journey and CR&T’s impact on her life.

We are deeply grateful to the generous friends who make our achievements possible. If you would like to help CR&T continue our important work in 2022 and beyond, please click here.

Ruth Fein Revell:  A Patient’s MPN Journey

Ruth Fein Revell is an accomplished health/science writer whose work has appeared in The New York Times and many other media outlets. The many health challenges she has faced – including 25 years progressing from one MPN to another – in addition to early colon cancer and now myelofibrosis – have made her a dynamic MPN patient advocate.

In this video, Ruth tells her story and explains why CR&T and the Silver Center are close to her heart.

Play Video

CR&T-Funded Study: Normal Life Expectancy is Possible for Polycythemia Vera Patients (no changes)

This outstanding research was made possible by generous friends like you.

Please help CR&T continue our support of this life-changing work by making a year-end contribution today. Thank you for making a difference – and warm wishes to you and yours for a happy and healthy holiday season!

CR&T-Funded Study: Normal Life Expectancy is Possible for Polycythemia Vera Patients

This December, the Annual Meeting of the American Society of Hematology
will feature six studies by CR&T-funded researchers at the Richard T. Silver, MD Myeloproliferative Neoplasms (MPN) Center at Weill Cornell Medicine

In the brief video below, Ghaith Abu Zeinah, MD, discusses one of these studies, which shows that polycythemia vera (PV) patients treated at the Silver MPN Center may have a lifespan approaching normal compared to the PV population in the U.S. overall. The practices outlined in this study could lead to new guidelines for monitoring and treating PV at centers nationwide and abroad. These dramatic results are due to the innovative treatment and multi-disciplinary care that patients receive at the Silver Center. 

Play Video

This outstanding research was made possible by generous friends like you.

Please help CR&T continue our support of this life-changing work by making a year-end contribution today. Thank you for making a difference – and warm wishes to you and yours for a happy and healthy holiday season!